Parkinson's disease (PD) is one of the most common neurological disorders caused by the death of dopamine-secreting neurons in the brain
The technical program will run in four sessions and a panel discussion on “Challenges in translation of medical technologies”
Acquisition to advance company's next generation biology portfolio with internationally recognized pioneer in organoid development
Partnership to supercharge LVMH Recherche with Integrated Biosciences’ innovative AI and synthetic biology platform for targeting skin aging
GFP is a common fusion protein tag that enables protein expression to be monitored, quantified, and localized within the complex environment of the cell
New research labs and process development services to enable next generation therapeutics
Bringing a new drug to market takes about 10 years and requires an investment of approximately $1 billion
This partnership is set to meet the growing demand for innovative life science research solutions in the Vietnamese market
MedGenome reaffirms its commitment to broaden access to quality and affordable genetic solutions for all
The company plans to advance Ropanicant into double-blind, placebo-controlled Phase-2b clinical study in MDD patients, anticipated to start in early 2025
Subscribe To Our Newsletter & Stay Updated
